Lowell Blake & Associates Inc. Novartis Ag Transaction History

Lowell Blake & Associates Inc.

$1.4 Billion
Q3 2023

A detailed history of Lowell Blake & Associates Inc. transactions in Novartis Ag stock. As of the latest transaction made, Lowell Blake & Associates Inc. holds 20,785 shares of NVS stock, worth $2.16 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

20,785

Previous 21,405 2.9%

Holding current value

$2.16 Million

Previous $2.16 Million 1.95%

% of portfolio

0.15%

Previous 0.63%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$94.73 - $105.13 $58,732 - $65,180	-620 Reduced 2.9%	20,785 $2.12 Million
Q2 2023 Aug 11, 2023	SELL	$92.52 - $104.91 $135,726 - $153,902	-1,467 Reduced 6.41%	21,405 $2.16 Million
Q1 2023 May 12, 2023	SELL	$80.03 - $92.81 $399,589 - $463,400	-4,993 Reduced 17.92%	22,872 $2.1 Million
Q4 2022 Feb 10, 2023	SELL	$75.55 - $92.52 $954,952 - $1.17 Million	-12,640 Reduced 31.21%	27,865 $2.53 Million
Q3 2022 Nov 14, 2022	SELL	$74.61 - $87.26 $345,145 - $403,664	-4,626 Reduced 10.25%	40,505 $3.08 Million
Q2 2022 Aug 11, 2022	SELL	$80.52 - $93.75 $1.85 Million - $2.15 Million	-22,947 Reduced 33.71%	45,131 $3.82 Million
Q1 2022 May 13, 2022	SELL	$80.11 - $90.62 $135,706 - $153,510	-1,694 Reduced 2.43%	68,078 $5.97 Million
Q4 2021 Feb 11, 2022	BUY	$79.7 - $88.13 $276,001 - $305,194	3,463 Added 5.22%	69,772 $6.1 Million
Q3 2021 Oct 15, 2021	BUY	$81.78 - $95.14 $104,024 - $121,018	1,272 Added 1.96%	66,309 $5.42 Million
Q2 2021 Jul 29, 2021	SELL	$85.24 - $94.15 $43,813 - $48,393	-514 Reduced 0.78%	65,037 $5.93 Million
Q1 2021 May 06, 2021	BUY	$83.5 - $98.47 $1.58 Million - $1.87 Million	18,963 Added 40.7%	65,551 $5.6 Million
Q4 2020 Feb 04, 2021	BUY	$78.07 - $94.43 $181,903 - $220,021	2,330 Added 5.26%	46,588 $4.4 Million
Q3 2020 Oct 22, 2020	BUY	$82.14 - $91.0 $253,648 - $281,008	3,088 Added 7.5%	44,258 $3.85 Million
Q2 2020 Aug 13, 2020	BUY	$80.93 - $91.1 $319,754 - $359,936	3,951 Added 10.62%	41,170 $3.6 Million
Q1 2020 Jul 01, 2020	BUY	$70.67 - $99.01 $202,610 - $283,861	2,867 Added 8.35%	37,219 $3.07 Million
Q4 2019 Jul 01, 2020	BUY	$84.35 - $95.37 $2.9 Million - $3.28 Million	34,352 New	34,352 $3.25 Million

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $223B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lowell Blake & Associates Inc., based on Form 13F filings with the SEC.

News

Stay updated on Lowell Blake & Associates Inc. with notifications on news.

Account

Lowell Blake & Associates Inc. Novartis Ag Transaction History